Cell Reports (Aug 2016)

The RNA Binding Protein Mex-3B Is Required for IL-33 Induction in the Development of Allergic Airway Inflammation

  • Yusuke Yamazumi,
  • Oh Sasaki,
  • Mitsuru Imamura,
  • Takeaki Oda,
  • Yoko Ohno,
  • Yumi Shiozaki-Sato,
  • Shigenori Nagai,
  • Saki Suyama,
  • Yuki Kamoshida,
  • Kosuke Funato,
  • Teruhito Yasui,
  • Hitoshi Kikutani,
  • Kazuhiko Yamamoto,
  • Makoto Dohi,
  • Shigeo Koyasu,
  • Tetsu Akiyama

DOI
https://doi.org/10.1016/j.celrep.2016.07.062
Journal volume & issue
Vol. 16, no. 9
pp. 2456 – 2471

Abstract

Read online

Allergic airway inflammation is one of the primary features of allergic asthma. Interleukin-33 (IL-33) is recognized as a key pro-inflammatory cytokine that mediates allergic airway inflammation, and its expression is elevated in this condition, but little is known about the regulatory mechanisms underlying IL-33 induction. Here, we show that the RNA binding protein Mex-3B plays a critical role in the induction of IL-33 in the development of allergic airway inflammation. We generated Mex3b−/− mice and found that they develop significantly less airway inflammation than wild-type mice due to reduced induction of IL-33. Furthermore, we show that Mex-3B directly upregulates IL-33 expression by inhibiting miR-487b-3p-mediated repression of IL-33. Moreover, we show that inhalation of an antisense oligonucleotide targeting Mex-3B suppresses allergic airway inflammation. Our data identify a signaling pathway that post-transcriptionally regulates IL-33 expression and suggest that Mex-3B could be a promising molecular target for the treatment of allergic asthma.